Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Microba Life Sciences's change in inventory for the quarter that ended in Dec. 2025 was €0.00 Mil. It means Microba Life Sciences's inventory
stayed the same
from Jun. 2025 to Dec. 2025 .
Microba Life Sciences's change in inventory for the fiscal year that ended in Jun. 2025 was €0.00 Mil. It means Microba Life Sciences's inventory
stayed the same
from Jun. 2024 to Jun. 2025 .
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Microba Life Sciences's Days Inventory for the quarter that ended in Dec. 2025 was 91.74.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Microba Life Sciences's Inventory Turnover for the quarter that ended in Dec. 2025 was 1.99.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Microba Life Sciences's Inventory-to-Revenue for the quarter that ended in Dec. 2025 was 0.27.
3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Microba Life Sciences's Inventory to Revenue for the quarter that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Microba Life Sciences Change In Inventory Related Terms
Microba Life Sciences Change In Inventory Historical Data
* Premium members only.
The historical data trend for Microba Life Sciences's Change In Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Microba Life Sciences Change In Inventory Calculation
Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.
Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Change In Inventory of €0.00 Mil mean?
Microba Life Sciences (FRA:F3Y) has a Change In Inventory of €0.00 Mil as of Dec. 2025. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Microba Life Sciences and its competitors.
Is Microba Life Sciences' Change In Inventory too high?
Microba Life Sciences' current Change In Inventory is €0.00 Mil. Overall, Microba Life Sciences has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Microba Life Sciences' Change In Inventory compare to TMO and DHR?
Microba Life Sciences' Change In Inventory of €0.00 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Medical Diagnostics & Research company?
A good Change In Inventory depends on the Medical Diagnostics & Research industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Microba Life Sciences and its competitors. Microba Life Sciences's current Change In Inventory is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Microba Life Sciences stock overvalued right now?
Microba Life Sciences (FRA:F3Y) has a current Change In Inventory of €0.00 Mil. The stock's GF Value™ is €0.12, compared to a current price of €0.02 — trading 79.6% below its estimated fair value. The current Change In Inventory is €0.00 Mil. Microba Life Sciences' overall GF Score™ is 29/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Microba Life Sciences (FRA:F3Y), the current Change In Inventory is €0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Microba Life Sciences (FRA:F3Y) Overvalued in 2026?
Based on GuruFocus' analysis, Microba Life Sciences stock appears to be undervalued.
The current stock price of €0.02 is trading 79.6% below its estimated GF Value™ of €0.12.
Key valuation signals for FRA:F3Y:
Change In Inventory: €0.00 Mil
GF Value™: €0.12 vs. price of €0.02 (79.6% below fair value)
No single metric tells the full story. See the FRA:F3Y stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Microba Life Sciences Ltd is a commercial-stage company with technology for measuring the human gut microbiome and engages in providing gut microbiome testing services globally to consumers, clinicians, and researchers. It is also involved in developing new pathology services, therapeutics, and diagnostics based on the human gut microbiome. The company's operating segments are: Testing Services and Supplements, which derive key revenue, and Research and Development. Geographically, the company derives maximum revenue from Australia and the rest from Europe, New Zealand, the United States, Asia, and other regions.
29GF Score
Get the complete analysis for FRA:F3Y
Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:F3Y has been successfully added to your 
